Inhaled corticosteroids for COPD patients in polluted air
Part of Lungs & breathing clinical trials.
This study tests whether inhaled corticosteroids (a common type of COPD inhaler) can help reduce the harmful effects of air pollution on your lungs. If you have mild to moderate COPD, joining this trial could show how well your current treatment protects you from everyday air pollution.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 40 and 80.
- You have been diagnosed with mild to moderate COPD (also called stage 1 or 2).
- You have not smoked and have not used any tobacco products for at least the last 6 months.
- You have not had a COPD flare-up (exacerbation) in the past year.
- You do not have a history of asthma or asthma-COPD overlap.
- If you are a woman who could become pregnant, you must not be pregnant, planning a pregnancy, or breastfeeding, and you must have a negative pregnancy test before joining.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new approach can help relieve severe shortness of breath in people with COPD who are already on standard inhaler therapy. It may help you breathe easier and improve your daily life.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study looks at different lung immune cell patterns and how they work in smokers who are not yet diagnosed with COPD or asthma. It may help researchers understand why some people are more likely to develop COPD, which could guide future prevention or early treatments.
This study uses computer modeling to see how much of your inhaled medication reaches your lungs. It helps doctors understand how to better treat breathing conditions like asthma or COPD.
This study compares the lungs of people with airway disease to healthy volunteers to understand inflammation and lung function. You may be eligible if you have airway disease or are a healthy adult.
This study tests how a bronchodilator (a medicine that opens airways) affects breathing and exercise in people with COPD. It aims to understand if it helps you breathe easier during physical activity.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.